Updates on COVID19
There is an increased rate of hospital-diagnosed coronavirus disease 2019 (COVID-19) cases associated with chronic inflammatory or autoimmune conditions, including systemic autoimmune or immune-mediated inflammatory diseases (AI/IMIDs), according to study results published in the Annals of the Rheumatic Diseases.
The risks seem to depend on age, the specific disease, and previous therapies; remarkably increased rates were observed in biologic or targeted synthetic but not in conventional disease-modifying antirheumatic drug-treated patients.
Researchers concluded, “These data provide a basis to improve preventive recommendations to patients [with the rheumatic disease] and to analyze the specific factors involved in COVID-19 susceptibility.”
In summary: Prevention, prevention for our rheumatology patients. COVID 19 is real don’t be fooled for more look up this article :
Pablos JL, Abasolo L, Alvaro-Garcia JM, , et al. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases [published June 12, 2020]. Ann Rheum Dis. doi:10.1136/annrheumdis-2020-217763
